8-Epi-iridodial glucoside from Boschniakia rossica.

8-Epi-iridodial glucoside from Boschniakia rossica. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

8-Epi-iridodial glucoside from Boschniakia rossica. Abstract Text:

F Murai,M Tagawa,

Boschnaside, 8-epi-iridodial glucoside a new iridoid glucoside was isolated from BOSCHNIAKIA ROSSICA H ULT., and its absolute structure was determined by chemical correlation of boschnaloside tetraacetate with boschnaside tetraacetate.

8-Epi-iridodial glucoside from Boschniakia rossica. Publishing Authors By Initials

F Murai,M Tagawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

8-Epi-iridodial glucoside from Boschniakia rossica. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Planta medica

VOLUME: 46

Page Numbers: 45-7

Journal Abbreviation: Planta Med.

ISSN: 0032-0943

DAY: 2

MONTH: Sep

YEAR: 1982

8-Epi-iridodial glucoside from Boschniakia rossica. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 66751

8-Epi-iridodial glucoside from Boschniakia rossica. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: 8-Epi-iridodial glucoside from Boschniakia rossica. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for 8-Epi-iridodial glucoside from Boschniakia rossica.

AFFILIATION: Laboratory of Chemistry, Aichi Medical University, Nagakute, Aichi, Japan.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Planta Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

8-Epi-iridodial glucoside from Boschniakia rossica Related Publications

• 8-Epi-iridodial glucoside from Boschniakia rossica.
• A direct colorimetric method for the determination of phospholipids with dithiocyanatoiron reagent.
• A simple method for measuring phosphatidylcholine as its hydrophobic complex with tetrathiocyanatocobaltate.
• A stabilizing factor of yeast mitochondrial F1F0-ATPase-inhibitor complex: common amino acid sequence with yeast ATPase inhibitor and E. coli epsilon and bovine delta subunits.
• Amino acid sequence of an intrinsic inhibitor of mitochondrial ATPase from yeast.
• An immuno-light- and electron-microscopic study of the expression of bone morphogenetic protein-2 during the process of ectopic bone formation in the rat.
• Binding of intrinsic ATPase inhibitor to mitochondrial ATPase--stoichiometry of binding of nucleotides, inhibitor, and enzyme.
• Binding properties of 9K protein to F1-ATPase: a counterpart ligand to the ATPase inhibitor.
• Binding properties of an intrinsic ATPase inhibitor and occurrence in yeast mitochondria of a protein factor which stabilizes and facilitates the binding of the inhibitor to F1F0-ATPase.
• Botulinum toxin treatment for blepharospasm associated with myasthenia gravis.
• Cell-free synthesis of mitochondrial ATPase inhibitor precursor and its transport into yeast mitochondria.
• Change in P-450 content accompanying aerobic formation of mitochondria in yeast.
• Characterization of the development of ectopic chondroid/bone matrix and chondrogenic/osteogenic cells during osteoinduction by rhBMP-2: a histochemical and ultrastructural study.
• Decrease in mitochondrial levels of adenine nucleotides and concomitant mitochondrial dysfunction in ischemic rat liver.
• Development of mitochondrial membranes in anaerobically grown yeast cells.
• Energy-independent protection of the oxidative phosphorylation capacity of mitochondria against anoxic damage by ATP and its non-metabolizable analogs.
• Existence of stoichiometric amounts of an intrinsic ATPase inhibitor and two stabilizing factors with mitochondrial ATP synthase in yeast.
• Hepatic accumulation of pyrophosphate during acetate metabolism.
• Interaction of mitochondrial aspartate aminotransferase with negatively charged lecithin liposomes.
• Involvement of Ca2+ release and activation of phospholipase A2 in mitochondrial dysfunction during anoxia.
• Kinetics of hydroperoxide degradation by NADP-glutathione system in mitochondria.
• Localization of cytochrome c peroxidase in anaerobically grown yeast cells.
• Non-mitochondrial electron transfer system in anaerobically grown yeast cells.
• Partial amino terminal sequence of the precursor of mitochondrial ATPase inhibitor protein synthesized with mRNA partially purified by gel permeation chromatography.
• Properties of binding sites for adenine nucleotides on ATPase from yeast mitochondria.
• Purification and properties of factors in yeast mitochondria stabilizing the F1F0-ATPase-inhibitor complex.
• Simultaneous bindings of ATPase inhibitor and 9K protein to F1F0-ATPase in the presence of 15K protein in yeast mitochondria.
• [Hypertension in dialysis patients]
• [Hypotension in dialysis patients]
• pH-Induced conformational change of ATPase inhibitor from yeast mitochondria. A proton magnetic resonance study.